Tech Company Financing Transactions

Genesis Therapeutics Funding Round

Genesis Therapeutics secured a $52 million Series A venture capital round on 12/3/2020. Investors included Rock Springs Capital, Andreessen Horowitz and Felicis Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

415 Grand Ave. 201
San Francisco, CA 94080
USA

Phone

Undisclosed

Website

www.genesistherapeutics.ai

Email Address

[email protected]

Overview

Genesis Therapeutics is a biotechnology company that invents and deploys breakthrough AI techniques to discover and develop drugs both internally as well as in select partnerships. Genesis is unique in its groundbreaking deep learning technology, its synergy of machine learning with biophysical simulation and its pairing of AI with extensive biotech/pharma expertise.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Leonard Bell

        

Chief Executive Officer

Evan Feinberg

        

Chief Scientific Officer

Peppi Prasit

        

Vice President

Nick Stock

        

VP - Bus. Development

James Schaeffer

        

VP - Engineering

Benjamin Sklaroff

        

Browse more venture capital transactions:

Prev: 12/3/2020: Orbit venture capital transaction
Next: 12/3/2020: Jitsu venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary